VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LFMD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LFMDLifeMD, Inc.
$4.13$200M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksLFMDCash Flow

LifeMD, Inc. (LFMD) Cash Flow Statement

15Y historyFree accessUpdated daily

Cash flow remains highly unstable, with free cash flow swinging from a $11.5 million peak in 2025Q2 to a $3.4 million deficit in 2025Q4, complicated by a persistent $776.6K quarterly dividend payment despite ongoing net losses.

LFMD Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Cash from Operations5.66M8.28M17.51M8.82M-22.94M-33.09M-12.13M251.41K-905.52K-817.22K-407.91K-295.12K33.44K-259.07K-229.73K-17.69K
Operating CF Margin %-4.27%8.24%5.78%-19.27%-35.62%-32.53%2.02%-10.88%-16.17%-7.79%-24.21%4.68%-32.05%-34.1%-2.38%
Operating CF Growth %-406.75%-52.72%98.56%138.46%30.68%-172.72%-4925.47%127.76%-10.81%-100.34%-38.22%-982.57%112.91%-12.78%-1198.91%-
Net Income-17.03M15.62M-18.73M-20.6M-45.02M-61.32M-60.52M-3.53M-1.36M-1.21M-1.22M-159.23K-460.49K-268.26K-445.65K-502.93K
Depreciation & Amortization-2.76M328.37K9.49M6.6M3.77M868.76K397.76K335.61K195.78K91.56K33.72K43.75K56.98K56.97K56.97K56.69K
Stock-Based Compensation7.95M10.5M12.23M12.49M13.73M12.07M18.66M733.22K273.57K162.74K587.99K142.3K125.5K105K84K400K
Deferred Taxes0000354K0914.86K66K4K-90.28K37.42K-13.2K-17.2K-17.2K-17.2K-17.2K
Other Non-Cash Items-4.94M-10.31M1.87M5.42M5.78M6.17M19.63M578.61K237.2K918.01K33.72K-127.26K80.5K48.75K122.31K-17.2K
Working Capital Changes4.9M-7.85M12.65M4.91M-1.55M9.13M8.8M2.07M-255.97K-693.28K122.54K-181.48K328.65K-184.34K-30.16K45.75K
Change in Receivables2.58M1.15M-2.94M-2.44M-2.19M17.7K-550.97K1.6K29.14K95.09K-361.44K-139.47K62.51K-27.79K-13.33K43.97K
Change in Inventory399.77K303.24K675.67K764.33K-2.18M-409.82K-314.2K72.56K-341.36K-546.89K-99.22K-20.04K45.19K-22.82K-4.58K46.2K
Change in Payables11.08M3.24M4.92M978.06K1.25M-893.96K8.93M1.89M6.34K-227.23K585.45K-21.97K88.96K-1.73K-12.24K-134.41K
Cash from Investing7.72M6.91M-11.54M-8.73M-13.91M-3.4M-798.14K-100K141.44K63.38K219.89K127.26K0000
Capital Expenditures-1.02M0-1.49M-203.81K-366.63K-247.37K-398.14K0-100K0000000
CapEx % of Revenue0.46%0.96%0.7%0.13%0.31%0.27%1.07%-1.2%-------
Acquisitions0000-1.01M0-400K-100K241.44K63.38K219.89K00000
Investments----------------
Other Investing8.74M6.91M-10.05M-8.53M-12.53M-3.15M0-100K290K00127.26K0000
Cash from Financing-13.29M-13.41M-4.12M29.1M-528.2K68.64M21M775.12K802.79K776.03K357.49K325.35K-113K315.2K295.15K51.19K
Debt Issued (Net)-18.72M-18.72M-327.6K16.67M2.74M-530.82K93.19K798.28K642.44K116.06K131.4K158K-13K40.2K-50.73K-142.31K
Equity Issued (Net)9.27M9.19M016.2M069.33M20.13M350K0596.6K-23.8K-10.8K0175K345.88K193.5K
Dividends Paid-3.11M-3.11M-3.11M-3.11M-3.11M-871.48K-1.29M0000-10.8K0000
Share Repurchases000000000-76.65K-87.05K-10.8K0000
Other Financing-737.66K-773.66K-684.83K-667.63K-159.2K707.36K2.07M-373.15K160.35K63.38K249.89K188.95K-100K100K00
Net Change in Cash84.73K1.78M1.86M29.19M-37.37M32.15M8.07M926.53K38.71K-41.18K-50.42K157.49K-79.56K56.13K65.43K33.5K
Free Cash Flow14.83M6.41M5.98M86.95K-35.83M-36.49M-12.53M251.41K-1.01M-817.22K-407.91K-295.12K33.44K-259.07K-229.73K-17.69K
FCF Margin %6.76%3.3%2.81%0.06%-30.1%-39.29%-33.6%2.02%-12.08%-16.17%-7.79%-24.21%4.68%-32.05%-34.1%-2.38%
FCF Growth %368.41%7.24%6774.08%100.24%1.81%-191.21%-5083.83%125%-23.04%-100.34%-38.22%-982.57%112.91%-12.78%-1198.91%-
FCF per Share0.310.140.150.00-1.16-1.35-0.880.03-0.11-0.09-0.06-0.050.01-0.04-0.04-0.00
FCF Conversion (FCF/Net Income)-0.87x-1.17x-0.93x-0.43x0.50x0.54x0.21x-0.08x0.73x0.68x0.37x4.76x-0.07x0.97x0.52x0.04x
Interest Paid0000189K435.05K0000000000
Taxes Paid0000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

High Customer Acquisition Costs

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Lacks Cash Alignment

As reported in quarterly financial statements, LifeMD's operating cash flow frequently diverges from net income, with the OCF/NI ratio reaching an extreme -4.16 in 2025Q2, suggesting that reported earnings are not currently serving as a reliable proxy for the company's actual cash-generating capabilities.

The persistent gap between net income and operating cash flow indicates that non-cash items and working capital fluctuations are heavily influencing the bottom line. Investors should monitor whether this disconnect reflects aggressive accrual accounting or simply the inherent volatility of a business model reliant on high-volume, low-margin customer acquisition.

Free Cash Flow Volatility Persists

Based on the company's reported figures, free cash flow has exhibited significant instability, swinging from a peak of $11.5 million in 2025Q2 to a deficit of $3.4 million in 2025Q4, highlighting the difficulty in maintaining consistent cash generation amidst a contracting revenue environment.

The erratic nature of FCF margins suggests that the company's cash flow is highly sensitive to timing differences in marketing spend and subscriber renewals. This lack of predictability makes it difficult to determine if the business is truly approaching a sustainable self-funding inflection point.

Working Capital Swings Mask Burn

According to recent SEC filings, working capital changes have been a primary driver of cash flow volatility, with a notable $5.7 million inflow in 2026Q1 contrasting with a $5.2 million outflow in 2025Q4, indicating that operational cash flow is heavily dependent on timing shifts.

These large swings in working capital suggest that the company may be managing its payables and receivables aggressively to smooth out cash flow reporting. Such reliance on working capital management to bolster liquidity warrants further investigation into the underlying health of the core subscription business.

Capital Allocation Prioritizes Dividend Payments

As disclosed in financial statements, LifeMD has maintained a consistent quarterly dividend payment of approximately $776.6K despite reporting net losses in most periods, which appears to be a strategic choice to return capital to shareholders while the core business remains in a cash-burning phase.

The decision to continue dividend payments while operating cash flow remains inconsistent suggests a management focus on shareholder optics. However, this capital allocation strategy may limit the resources available for reinvestment into the clinical infrastructure necessary to drive long-term, non-marketing-dependent growth.

LFMD — Frequently Asked Questions

Quick answers to the most common questions about buying LFMD stock.

How much cash does LifeMD, Inc. (LFMD) generate from operations?

LifeMD, Inc. (LFMD) generated $8.3M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is LifeMD, Inc.'s free cash flow?

LifeMD, Inc. (LFMD) generated $6.4M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is LifeMD, Inc.'s capital expenditure (CapEx)?

LifeMD, Inc. (LFMD) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does LifeMD, Inc. distribute cash to shareholders?

In 2025, LifeMD, Inc. (LFMD) returned $3.1M to shareholders via cash dividends. This shows the company's commitment to returning capital to its equity investors.